Abstract:Background: Gastric cancer (GC) is a refractory malignant tumor with high tumor heterogeneity, a low rate of early diagnosis, and poor patient prognosis. Lipid metabolism reprogramming plays a critical role in tumorigenesis and progression, but its prognostic role and regulatory mechanism in GC are rarely studied. Thus, the identification of signatures related to lipid metabolism is necessary and may present a new avenue for improving the overall prognosis of GC. Methods: Lipid metabolism-associated genes (LMAGs) with differential expression in tumor and tumor-adjacent tissue were acquired to identify lipid metabolism-associated subtypes. The differentially expressed genes (DEGs) between the two clusters were then utilized for prognostic analysis and signature construction. Additionally, pathway enrichment analysis and immune cell infiltration analysis were employed to identify the characteristics of the prognostic model. Further analyses were conducted at the single-cell level to better understand the model's prognostic mechanism. Finally, the prediction of immunotherapy response was used to suggest potential treatments. Results: Two lipid metabolism-associated subtypes were identified and 9 prognosis-related genes from the DEGs between the two clusters were collected for the construction of the prognostic model named lipid metabolism-associated signature (LMAS). Then we found the low LMAS patients with favorable prognoses were more sensitive to ferroptosis in the Cancer Genome Atlas of Stomach Adenocarcinoma (TCGA-STAD). Meanwhile, the tumor cells exhibiting high levels of lipid peroxidation and accumulation of reactive oxygen species (ROS) in single-cell levels were primarily enriched in the low LMAS group, which was more likely to induce ferroptosis. In addition, endothelial cells and cancer-associated fibroblasts (CAFs) facilitated tumor angiogenesis, proliferation, invasion, and metastasis through endothelial-mesenchymal transition (EndMT), affecting the prognosis of the patients with high LMAS scores. Moreover, CD1C- CD141- dendritic cells (DCs) also secreted pro-tumorigenic cytokines to regulate the function of endothelial cells and CAFs. Finally, the patients with low LMAS scores might have better efficacy in immunotherapy. Conclusions: A LMAS was constructed to guide GC prognosis and therapy. Meanwhile, a novel anti-tumor effect was found in lipid metabolism reprogramming of GC which improved patients' prognosis by regulating the sensitivity of tumor cells to ferroptosis. Moreover, EndMT may have a negative impact on GC prognosis.

Monoacylglycerol Lipase (MAGL) Knockdown Inhibits Tumor Cells Growth in Colorectal Cancer

Inhibition of Monoacylglycerol Lipase Restrains Proliferation, Migration, Invasion, Tumor Growth and Induces Apoptosis in Cervical Cancer.

Monoacylglycerol Lipase Inhibitor JZL184 Regulates Apoptosis and Migration of Colorectal Cancer Cells.

Effect of monoacylglycerol lipase on the tumor growth in endometrial cancer

Monoacylglycerol Lipase Knockdown Inhibits Cell Proliferation and Metastasis in Lung Adenocarcinoma

Prognostic Significance of Chemokines CCL11 and CCL5 Modulated by Low-Density Lipoprotein Cholesterol in Colon Cancer Patients with Normal Body Mass Index

ANGPTL1 Attenuates Colorectal Cancer Metastasis by Up-Regulating Microrna-138

Monoacylglycerol Lipase Promotes Progression of Hepatocellular Carcinoma Via NF-κB-mediated Epithelial-Mesenchymal Transition

The Effects of Monoacylglycerol Lipase on M2-like Tumor-Associated Macrophages-Induced Lung Metastasis of MHCC97H Cells

[Effect of Monoacylglycerol Lipase with Proliferation of MHCC97H Human Liver Cancer Cells in Vivo].

Monoacylglycerol Lipase Regulates Cannabinoid Receptor 2-Dependent Macrophage Activation and Cancer Progression

Monoacylglycerol Lipase Regulates Macrophage Polarization and Cancer Progression in Uveal Melanoma and Pan-Cancer

Enhanced Monoacylglycerol Lipolysis by ABHD6 Promotes NSCLC Pathogenesis

Monoacylglycerol Lipase Promotes Metastases in Nasopharyngeal Carcinoma.

Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-κB activation and promotes docetaxel efficacy in prostate cancer

Downregulation of MGLL and microRNAs (miR-302b-5p, miR-190a-3p, miR-450a-2-3p) in non-small cell lung cancer: potential roles in pathogenesis

Magnolin Promotes Autophagy And Cell Cycle Arrest Via Blocking Lif/Stat3/Mcl-1 Axis In Human Colorectal Cancers

Knockdown of Microtubule Associated Serine/threonine Kinase Like Expression Inhibits Gastric Cancer Cell Growth and Induces Apoptosis by Activation of ERK1/2 and Inactivation of NF-κB Signaling

Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles

Lobetyolin inhibits cell proliferation and induces cell apoptosis by downregulating ASCT2 in gastric cancer

Tumor microenvironment characteristics of lipid metabolism reprogramming related to ferroptosis and EndMT influencing prognosis in gastric cancer